Our reviewer saw scenes that included pitch blackness punctuated by torchlight and rumbling soundscapes to unnerve even the ...

In Jaden Smith’s case, that appeared to be a massive model of a spooky haunted house. So, to give his look a bit of drama, the musician and Karate Kid actor was seen sporting a headpiece in the ...

Pilot Mike Slack was in the cockpit during a descent into Ronald Reagan Washington National Airport nearly two decades ago when he noticed something on the runway. Mr Slack, a licensed pilot and ...

Obesity biotech Metsera and renal and metabolic-focused Maze Therapeutics have met their IPO expectations as the two companies prepare to join the Nasdaq this morning. While Metsera is offering ...

It’s no small thing that they were both drawn to the post-apocalyptic sci-fi romance Love Me, the debut feature from ... with an even more harrowing depiction of our near-future.

Metsera and Maze Therapeutics are the second and third biotechnology firms this year to go public, raising $275 million and $140 million, respectively, in a pair of new stock offerings priced Thursday ...

A public consultation has been launched on plans for a £600 million theme park in north Oxfordshire. Puy du Fou, which currently has a park in Les Epesses, France, and in Toledo, Spain, has ...

Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a phase 2 trial. The Bay Area-based biotech unveiled its ambition earlier ...

Maze seeks as much as $133 mln in New York IPO Backers include Alphabet's GV and Third Rock Ventures Biotech IPOs set for ramp up in coming weeks Jan 27 (Reuters) - Drug developer Maze ...

James is a published author with four pop-history and science books to his name. He specializes in history, strange science, and anything out of the ordinary.